ReXceptor

Pharma

Repurposed cancer drug to enter Phase I trials for Alzheimer’s disease this year

In the world of Alzheimer’s disease drugs, the past year has been marked by disappointing Phase 3 clinical trial results for a handful of much-anticipated antibody drugs. But the failure of those drugs, designed to clear toxic beta amyloid plaques that accumulate in the brain, isn’t discouraging to Cleveland startup ReXceptor Inc., which has just […]

By Deanna Pogorelc

Pharma

Alzheimer’s researchers form company, look to clinical trial of cancer drug

Researchers from Case Western Reserve University made a big splash earlier this year when they published research that showed a skin cancer drug reversed Alzheimer’s disease in mice. Now, the researchers have formed a company, ReXceptor, to begin tests that could determine whether the already approved cancer drug, called bexarotene (brand name Targretin), could have […]

By Brandon Glenn